Use of natalizumab in persons with multiple sclerosis: 2022 update
Sarah A. Morrow, Fraser Clift, Virginia Devonshire, Emmanuelle Lapointe, Raphaël Schneider, Mark Stefanelli, Reza Vosoughi
Topics & Concepts
NatalizumabMedicineMultiple sclerosisProgressive multifocal leukoencephalopathyDosingAdverse effectIntensive care medicineInternal medicineImmunologyPolyomavirus and related diseasesMultiple Sclerosis Research StudiesViral Infections and Immunology Research